[As you read this, remember that these words were meant to be spoken. Not every sentence is necessarily complete and some repetition is useful in the spoken word that may not appear in a purely written form.]
Opening Remarks for
Unlocking Healthcare Innovations and Investments
21-February-2015
To begin, I would like to welcome
everyone to the today’ symposium on Unlocking
Healthcare Innovations & Investments. Today was organized by the Health
Care Business Association students, and I am very impressed by what they have
put together. Other sponsors include the
Johns Hopkins Carey Business School, the Johns Hopkins Bloomberg School of
Public Health, the Johns Hopkins Alumni Association, and Sage Growth Partners (a growing healthcare strategy, technology and marketing firm
focused on solving the complexities of healthcare in both provider and payer
settings.)
With introductions out of the way, let me offer a few thoughts
about investment and innovation in health care.
You will find that I tend to refer to investment in innovation in health care as I think that the two are
inseparable at this point. Of course
there are some things that work well that are worth further investment, but
there is lots of room for investment in innovation so I will focus on the two
together.
When I am asked to set the stage for today’s type of discussion,
I usually try to tie in something from popular culture. For today, I will quote and then paraphrase
some lyrics from the song Closing Time by
Semisonic. Until I looked for the lyrics to make sure I had the absolutely
correct wording, I had forgotten just how old the song is. It dates back to 1998. Think about all the innovations in health
care in the 17 years since that time—SARS had not happened; Ebola was not in
the news; measles outbreaks were rare; Medicare Part D and several other
innovations to Medicare and Medicaid have happened since; iPhones had not yet
been invented; there were no “health apps”.
Also, 17 years ago was already a decade after the first time I took a
course about the United States health care system in the fall of my sophomore
year. In 1988, we were just five years
after the first major change in how Medicare paid hospitals; we were just
passing the Medicare Catastrophic Coverage Act which would face repeal a year
later; and we were approaching a time of rapid new pharmaceutical development.
Having a view of 17 years since the song I am about to quote
and 27 years since my first course on the US health care system, provides me
with a lot to think about in terms of where innovations are necessary, what
might work and what might not, how to evaluate those potential innovations, and
how we might incentivize and value investment in those innovations.
In any case, a line that comes up more than once during Closing Time and serves as the line I
will quote states, “Every new beginning comes some other beginning’s end.” In
health care we could paraphrase to say, “Every innovation comes from some other
innovation’s obsolescence.” The rhythm
might not work as lyrics, but let’s ponder that for a moment. And let me repeat it: “Every innovation comes
from some other innovation’s obsolescence.”
How is this helpful?
I want to set up a juxtaposition of what we have and what we hope to get
from the health care system to drive our thinking about the opportunities for
investment in innovation.
Those of us seated here this morning recognize that those
opportunities are nearly endless. That
is part of what makes health care an incredibly exciting industry. And, if we extend from just “health care” to anything
having to do with individual or population health, the list of
opportunities for investment in innovations to replace other obsolescent
innovations grows even longer.
The long-term horizon on health care gives insight into the
fact that this message is not entirely new.
For many years, decades even,
we have heard about what must be done
in order to make the system work better and cost less with an impending sense
of crisis. Of course, I could have
written exactly the same sentence about
the sense of crisis when I took my first blue book exam in my first class on
the US health care system at the start of my sophomore year at Penn State. There were high and supposedly unsustainable
levels of expenditures. Rapid
inflation. Overutilization. And consumers who found it challenging to
distinguish between necessary and unnecessary care.
I’ve already listed a few changes in the past quarter
century. Some relate to the consumer
issue. For example with health apps,
there is much more information and it is much more easily accessible to
individuals who are acting more and more like consumers when they are
patients. This may help consumers become
“smarter” or learn how to use available information better. However, sometimes the amount of information
is so large that instead of differentiating between useful and not so useful
care, consumers are faced with differentiating between useful and not so useful
information. Innovations in financial incentives may rapidly increase the
reward for better care and a better ability to understand and seek appropriate
care.
Also in the 27 years, the federal government has continued
to pay for more of the costs and to pay for the costs for a greater proportion
of the population, and the private sector has entirely new roles. More of the coverage that is financed by
government ultimately goes through the private sector. There are new public-private partnerships,
and there are areas in which investors have found it profitable to bring their
money and invest in talent to make money and improve outcomes. All of this makes now a great time to consider the opportunities for investment in innovation in health
care.
Now, let’s ponder a little more deeply why the United States
(and really the world’s) health care systems and economies make the present an
incredibly rich time for innovation related to healthcare and ultimately anything
having to do with individual or public health. In other words, what past innovations are
becoming obsolescent and creating opportunities and needs for new ones?
My list of reasons is certainly not comprehensive. With the
intellectual talent in this room, we could spend the entire day just listing
and elaborating on challenges to individual and public health and the health
care that we rely on, alongside our behaviors, to maintain and improve
health. Among my list of reasons you
will find some that are clearly a matter of choice within the population and by
the government, some that are inexorable given basic demographic forces in the
United States and around the world, and some that are due to the system that
has been set up for delivering and financing care in the United States. Let me briefly discuss five opportunities for
investment in innovation.
The first comes from public health. In the news late last year and early this
year more than at any other time in the past several decades has been the
threats that arise from parents choosing not to have their children
vaccinated. With a sufficiently large proportion
of individuals unvaccinated in an area, the herd immunity that protected the
previously small number of unvaccinated individuals begins to disappear. The reasons for the choice not to vaccinate
are many. I am not here to discuss or
debate those reasons. However, I want to
acknowledge the threats that arise to population health from the choices of
individuals. An entire series of
innovations could address mechanisms of delivery that are perceived to be safer
and mechanisms for communication that are more successful in bringing to light
the risk-benefit comparison for vaccination.
A return to higher levels of vaccination would decrease demands on the
public health system that is forced to track and attempt to convince to
vaccinate, decrease expenditures treating measles, and minimize the risk of
death from measles. All of these goals
would be worthy of investment if an innovation in this area were on the
horizon. In this case, new innovations are
motivated by the perceived obsolescence of vaccinations as we have known them
in a subset of the population.
A second opportunity for investment in innovation also comes
from public health. Conditions like HIV,
SARS, and Ebola have captured the world’s attention as conditions that were
either new to humans or that seem to return to humans on a regular basis. The opportunities to innovate by developing
vaccinations, developing cures, and implementing improved ways to control are
many. The potential economic
consequences, in both high-income and low-income countries, are sufficient that
if new methods and strategies for control are developed there will be plenty of
opportunity for investment. A key
question for interventions for this set of threats is whether there is a way to
make the investment profitable for a private corporation or whether there will
have to be government investment or specific incentives to create the
opportunity for private profit. In this
case, the opportunity for innovation comes from the obsolescence of the ways in
which we deal with infection and the rapidity with which we learn about new
disease.
Third, the population is aging. The ratio of the number of
individuals who are at what has traditionally been thought of as “working age”
relative to the number of individuals who are at what has traditionally been
thought of as “retirement age” continues to shrink in the United States and
around the world. The ratios are moving
to levels previously unseen. The changes create numerous opportunities for investment
in innovation.
Innovations could increase productive and healthy life years
for older individuals. This could be
associated with consuming more in traditional post-retirement age. It could also be associated with keeping
individuals in the work force for longer periods of time. The market implications of keeping
individuals in the workforce longer may have an important impact on the health and
economic outcomes of the labor market for the rest of society. This makes the value of investment in
innovation in this area challenging to calculate.
There are also opportunities to maintain current length and quality
of life in more efficient and less costly ways that can be cost-effective and
beneficial to society. The economics may be as favorable as extending life and
health at a higher level of expense.
Controlling costs for current health outcomes would benefit society,
particularly taxpayers, while also directly benefiting older adults and their
families who would face lower out-of-pocket expenses and perhaps smaller
opportunity costs of their time with better care management.
Also related to aging is the opportunity for investment in
innovation related to dementia care—or better yet prevention or cure. The demands that are being placed on the
United States economy as a result of dementia are huge. The psychological and social costs are
growing as quickly as the economic costs.
Anyone who can find a way to slow or prevent the process will have the
potential to reap incredible returns on their investment.
Each of the opportunities for innovation having to do with
aging come from the obsolescence of an economic and cultural system in which a
specific age was deemed to be the “right” age for retirement and our systems of
caring for those who are frail are overly expensive with large burdens for the
individuals, their families, and society.
A fourth opportunity for investment in innovation, this time
more specifically in the United States, comes from employers and their
employees finding a greater proportion of the total compensation for workers
going to health insurance and health care even among the relatively healthy
working age population. So whether there
are new treatments, new guidelines, new measures of quality, or new incentives
to use the best care possible in as timely a manner as possible, the need for
investment in innovation is clear. The
obsolescence here is in aspects of the ways we have financed insurance and
provided care.
A fifth opportunity for investment in innovation comes from
the notable increase in the incidence of chronic disease that is related to
many things including earlier identification, earlier treatment, an expectation
of long-term savings (that do not always materialize), and earlier treatment triggers. All of these call for innovation in how we
manage conditions, how providers interact with patients, which providers
interact with patients, and the tools and information we give patients to
manage themselves. The obsolescence here
might be thought of as being a function of our understanding of how to prevent
and manage chronic conditions and how to manage health versus the rest of our
lives.
I have provided a list of five opportunities for investment
in innovation related to health care and to promote individual and population
health. Each of these deals with the
obsolescence of something in our health, economic, or social systems. The opportunities could result in new
treatments, new ways of managing care, new behaviors, new facilities (designed
with the patient and health management in mind in ways that we have never seen
before), new communications, or new social norms. These are just a subset of
the opportunities for bright minds who focus on design, or on looking for
sources of funding, or on the flow of funds from taxpayers to government to
educators and providers, or on the flow of funds from individuals to insurers
to providers, to think creatively about how to improve the organization and
financing of the health care system.
Where will we find the bright minds working? Healthcare innovations have come from both
the private and the public sectors. Just
because we are sitting in a business school does not mean we completely
eliminate the idea that government has something to contribute to
innovation. Rather, we recognize that
there is a role for government in supporting those who cannot pay on their own
as there is a common good in a healthy population. The key question is how to
best balance the public and private sector opportunities to provide funds for
innovation. That balance will come
through the public sector focus on research, or building infrastructure, and on
educating medical care providers. And the
private sector focus on bringing products to market including pharmaceuticals
and medical devices, emphasizing design principles in new products and
facilities, new ways of organizing care and new ways of managing care. To encourage these investments, the
government has a role in structuring the assessment of and incentives for potential
investments while the private sector determines how to structure investments to
maximize the probability of producing a positive outcome.
The lessons in innovation and investment and not only for
present and future health care leaders. These
are important for all industry leaders. Of course, there are some businesses
that are designed around keeping individuals or the population as a whole
healthy and preventing the need for health care. There are other businesses that are designed
specifically to provide health care to unhealthy individuals. Both are concerned about health—whether the goal
is just to slow the decline in health or the goal is to stabilize health or the
goal is to return the person to near perfect health as quickly as possible for
as long as possible.
An additional reason for all businesses to be concerned
about health is the school’s mission to teach business with humanity in
mind. As we think about the phrase, we
recognize that healthy businesses are located in healthy communities. Thus, all businesses should take an interest
in the health of their workers, the health of their customers, and the health
of the surrounding community. Productivity decreases with less healthy workers. And unhealthy consumers have less
discretionary income to spend on non-essential goods and services.
This does not mean that all businesses should using their
creative energies toward innovation in health and making investments in health
care. But the interest in health and
health care among business leaders should be both broad and deep.
I anticipate we will find today’s discussion of investments
that have been and can be made and innovations that have occurred and may occur
inspiring no mater where our careers take us.
Whether we plan to be directly in health care, in a related industry or
simply in an industry that relies on health.
We will hear from leaders who are in the private sector at present but
who have had career experiences in both the public and private sector at the
cutting edge of innovation and investment in the health care system and in
public health.
We will find the stories inspiring because we admire people
who experiment. We admire people who
bring resources to bear on taking risks. And whether the innovations are truly
game changers or incremental stepping stones on the path to the future, we admire
those who have found ways to push us and our economy ahead.
We will find the stories inspiring whether we hear about
successful results or the challenges of and the process of learning from
failure. Sometimes the best and most
important lessons we learn in our careers and for our businesses come in the
form of failures. And I anticipate that
the inspiration will be what may help to drive someone in this very room to
bring on the next major innovation or choice to make an investment somewhere in
their career that helps to move the US health care system toward a trajectory
that is more sustainable and results in a healthier population over time.
So now it is closing time for my comments. Let us move on to listening to stories of
innovations that come from some other innovation’s obsolescence.